What is the optimal lipid emulsion for preventing intestinal failure-associated liver disease following parenteral feeding in a rat model of short-bowel syndrome?

PURPOSE: Composite lipid emulsion (CLE) has been used for intestinal failure-associated liver disease (IFALD) to compensate for the disadvantages of soybean oil lipid emulsion (SOLE) or fish oil lipid emulsion (FOLE). However, the influence of its administration is unclear. We evaluated the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Machigashira, Seiro, Kaji, Tatsuru, Onishi, Shun, Yano, Keisuke, Harumatsu, Toshio, Yamada, Koji, Yamada, Waka, Matsukubo, Makoto, Muto, Mitsuru, Ieiri, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847428/
https://www.ncbi.nlm.nih.gov/pubmed/33388967
http://dx.doi.org/10.1007/s00383-020-04802-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847428/
https://www.ncbi.nlm.nih.gov/pubmed/33388967
http://dx.doi.org/10.1007/s00383-020-04802-0

Ejemplares similares